Supervisor Database Search
Guidance for ICAT Supervisors
The ICAT Supervisor list is reviewed annually by the partner universities and updated online in March/April each year.
You can read about the ICAT supervisor selection process and eligibility criteria below:
Terms of reference/guide to supervising ICAT Fellows.
You can read the terms of reference for supervisors actively supervising ICAT Fellows below:
Supervisor Database
Search for supervisors below. You can filter your search using the options and select multiple fields by holding CTRL (Cmd on Mac) + clicking multiple options in a list.
Full NameProfessor Cecilia O'Kane
Wellcome-Wolfson Institute for Experimental Medicine
Queen's University Belfast
Webpage:qub.ac.uk
Email hidden; Javascript is required.
- infectious disease and the immune system
- cell and developmental biology/regenerative medicine
- Other
Critical care
- Medicine
- Respiratory Medicine
We are a group of researchers focussed on developing new therapies for and understanding mechanisms in, inflammatory lung disease, in particular Acute Respiratory Distress Syndrome (ARDS). Our work spans the spectrum from basic human cell experiments in vitro through pre-clinical models to clinical trials in patients. We have a strong emphasis on testing therapies in human pre-clinical models before progressing to clinical studies. Our human pre-clinical models of ARDS include the ex vivo human perfused (and ventilated) lung, and LPS inhalation followed by BAL in healthy volunteers. We are one of only 2 centres in the UK to run the ex vivo lung model to test therapies for ARDS, and we have used the human LPS model to test a range of anti-inflammatory and pro-reparative therapeutics (Shyamsundar 2009 AJRCCM, Shyamsundar 2014 AJRCCM). More recently we have developed an interest in mesenchymal stromal cell (MSC) therapy as a novel therapy for ARDS and have obtained funding to progress to a clinical trial in ARDS.